Recombinant Human SYCN Protein，His & GST

The study of SYCN (Synaptotagmin-Ca2+ binding protein) recombinant proteins has garnered significant attention in the field of molecular biology and neuroscience due to its critical role in synaptic transmission and neurotransmitter release. SYCN is a member of the synaptotagmin family, which is characterized by its ability to bind calcium ions and facilitate the fusion of synaptic vesicles with the presynaptic membrane. This process is essential for effective communication between neurons and plays a fundamental role in various neurological processes, including learning and memory. Understanding the structure and function of SYCN at a molecular level can provide insights into its mechanisms of action and potential dysregulation in neurological disorders. Research involving SYCN recombinant proteins aims to explore their binding interactions, calcium sensitivity, and regulatory mechanisms, thereby elucidating their contribution to synaptic physiology. Additionally, recombinant protein technology allows for the production of large quantities of SYCN, enabling detailed biochemical and biophysical analyses that can further our understanding of synaptic dynamics. As such, the investigation of SYCN recombinant proteins not only advances our knowledge of synaptic function but also holds promise for developing therapeutic strategies for disorders associated with synaptic dysfunction, such as epilepsy, anxiety, and schizophrenia. Overall, the study of SYCN and its recombinant variants is vital for uncovering the complexities of neural communication and the underlying mechanisms of various neurological diseases.